Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.

about

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.

Item

http://www.wikidata.org/entity/Q55345918

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.

@en

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.

@nl

type

Item

label

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.

@en

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.

@nl

prefLabel

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.

@en

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.

@nl

P1476

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.

@en

P2093

Dana A M Mustafa

http://www.w3.org/2001/XMLSchema#string

Joachim G J V Aerts

http://www.w3.org/2001/XMLSchema#string

Johan M Kros

http://www.w3.org/2001/XMLSchema#string

Rute M S M Pedrosa

http://www.w3.org/2001/XMLSchema#string

P2860

The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation

Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors

The epithelial-mesenchymal transition generates cells with properties of stem cells

Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities

MYC is a metastasis gene for non-small-cell lung cancer

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.

Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases

P304

159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2018.00159

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29868480

http://www.w3.org/2001/XMLSchema#string

P932

5958181

http://www.w3.org/2001/XMLSchema#string